These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18496637

  • 1. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
    Sheng ZF, Xu K, Ma YL, Liu JH, Dai RC, Zhang YH, Jiang YB, Liao EY.
    Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J, Xu K, Wen G, Guo H, Li S, Wu X, Dai R, Sheng Z, Liao E.
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin-deficient mice.
    Kimura M, Miyazawa K, Tabuchi M, Maeda H, Kameyama Y, Goto S.
    Calcif Tissue Int; 2008 Feb; 82(2):137-47. PubMed ID: 18183447
    [Abstract] [Full Text] [Related]

  • 4. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
    Lloyd SA, Morony SE, Ferguson VL, Simske SJ, Stodieck LS, Warmington KS, Livingston EW, Lacey DL, Kostenuik PJ, Bateman TA.
    Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
    [Abstract] [Full Text] [Related]

  • 5. Effect of Reveromycin A on experimental tooth movement in OPG-/- mice.
    Tanaka M, Miyazawa K, Tabuchi M, Yabumoto T, Kadota M, Yoshizako M, Yamane C, Kawatani M, Osada H, Maeda H, Goto S.
    J Dent Res; 2012 Aug; 91(8):771-6. PubMed ID: 22674934
    [Abstract] [Full Text] [Related]

  • 6. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M, Kostenuik PJ, Giannobile WV.
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [Abstract] [Full Text] [Related]

  • 7. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 8. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
    Peng S, Liu XS, Zhou G, Li Z, Luk KD, Guo XE, Lu WW.
    J Bone Miner Res; 2011 Jun 01; 26(6):1272-82. PubMed ID: 21611968
    [Abstract] [Full Text] [Related]

  • 9. [Effect of different types of jumps on the expressions of IL-6, OPG and RANKL in rat tibia].
    Wang T, Zhang X, Li S.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep 01; 30(9):909-12. PubMed ID: 25200151
    [Abstract] [Full Text] [Related]

  • 10. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X, Ominsky MS, Stolina M, Warmington KS, Geng Z, Niu QT, Asuncion FJ, Tan HL, Grisanti M, Dwyer D, Adamu S, Ke HZ, Simonet WS, Kostenuik PJ.
    Bone; 2009 Oct 01; 45(4):669-76. PubMed ID: 19539794
    [Abstract] [Full Text] [Related]

  • 11. Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway.
    El-Baz FK, Saleh DO, Abdel Jaleel GA, Hussein RA, Hassan A.
    Biomed Pharmacother; 2019 Aug 01; 116():109017. PubMed ID: 31158803
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of bone resorption and growth of breast cancer in the bone microenvironment.
    Buijs JT, Que I, Löwik CW, Papapoulos SE, van der Pluijm G.
    Bone; 2009 Feb 01; 44(2):380-6. PubMed ID: 19041433
    [Abstract] [Full Text] [Related]

  • 13. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J, Izumi N, Kasahara H, Tagawa H, Chiba T, Nihei H.
    Nihon Jinzo Gakkai Shi; 2010 Feb 01; 52(8):1022-8. PubMed ID: 21254698
    [Abstract] [Full Text] [Related]

  • 14. Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice.
    Wendelboe MH, Thomsen JS, Henriksen K, Vegger JB, Brüel A.
    Bone; 2016 Jun 01; 87():27-36. PubMed ID: 27021151
    [Abstract] [Full Text] [Related]

  • 15. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y, Kasai H, Ose A, Serada M, Ishiguro M, Shiraki M, Tanigawara Y.
    Osteoporos Int; 2018 May 01; 29(5):1155-1163. PubMed ID: 29423715
    [Abstract] [Full Text] [Related]

  • 16. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
    Carvas JS, Pereira RM, Caparbo VF, Fuller P, Silveira CA, Lima LA, Bonfa E, Mello SB.
    Osteoporos Int; 2010 Oct 01; 21(10):1723-9. PubMed ID: 19997905
    [Abstract] [Full Text] [Related]

  • 17. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y.
    J Bone Miner Metab; 2005 Oct 01; 23(1):41-7. PubMed ID: 15616893
    [Abstract] [Full Text] [Related]

  • 18. Different responsiveness of alveolar and tibial bone to bone loss stimuli.
    Mavropoulos A, Rizzoli R, Ammann P.
    J Bone Miner Res; 2007 Mar 01; 22(3):403-10. PubMed ID: 17181394
    [Abstract] [Full Text] [Related]

  • 19. Zoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient mice.
    Bonnet N, Lesclous P, Saffar JL, Ferrari S.
    PLoS One; 2013 Mar 01; 8(3):e58726. PubMed ID: 23505553
    [Abstract] [Full Text] [Related]

  • 20. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y, Koide M, Furuya Y, Ninomiya T, Yasuda H, Nakamura M, Kobayashi Y, Takahashi N, Yoshinari N, Udagawa N.
    PLoS One; 2017 Mar 01; 12(9):e0184904. PubMed ID: 28937990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.